Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Neogenomics Inc NEO

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: Clinical Services, and Advanced Diagnostics. The Clinical Services segment provides various clinical-testing services related to oncology diagnostics, community-based oncology and pathology sales, patient engagement, and clinical decision support. The Clinical Services segment... see more

Bullboard (NDAQ:NEO)

View:
User Avatar Image
(2)
•••
  • snottersX
Post by snotterson Apr 06, 2022 11:00pm

Overview

NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them ...more  
User Avatar Image
(4)
•••
  • zeropointenergyX
Comment by zeropointenergyon Mar 19, 2021 2:45am

RE:spending US$4.5bn to expand capacity at plants in the Chines

China EV startup Nio's shipments are beginning to take off    Nice read!
User Avatar Image
(4)
•••
  • zeropointenergyX
Post by zeropointenergyon Mar 19, 2021 2:37am

spending US$4.5bn to expand capacity at plants in the Chines

Chinese new-vehicle sales on road to recovery in 2021 ... www.eiu.com › Home › The EIU Update     Feb. 23, 2021 — China's ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >